SRZN - Surrozen, Inc./De

Insider Purchase by Column Group III Gp, LP (10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Column Group III Gp, LP, serving as 10% owner at Surrozen, Inc./De (SRZN), purchased 32,507 shares at $19.74 per share, for a total transaction value of $641,597.00. Following this transaction, Column Group III Gp, LP now holds 2,261,777 shares of SRZN.

This purchase represents a 1.00% increase in Column Group III Gp, LP's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, January 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 20, 2026, 5 days after the trade was made.

Surrozen, Inc./De operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Column Group III Gp, LP

Column Group III Gp, LP

10%

Column Group III GP, LP is the general partner of The Column Group III LP, a venture capital fund managed by The Column Group (TCG), a San Francisco-based firm dedicated to fueling life sciences innovation through company formation and investments across the development lifecycle.[[2]](https://aum13f.com/fund/the-column-group-iii-lp)[[5]](https://www.thecolumngroup.com/tcg-team/)[[6]](https://www.thecolumngroup.com) Established with a $239.5 million fundraise in 2016, it operates as a Venture Capital Fund focused on biotech, with offices at 1700 Owens Street, San Francisco, CA, and is audited by KPMG.[[2]](https://aum13f.com/fund/the-column-group-iii-lp) As a corporate insider, Column Group III GP, LP holds significant stakes in portfolio companies, including approximately 34% ownership in Surrozen, Inc. (SRZN) as of recent 13D/G filings (1,265,276 shares valued at around $18 million), with transactions reported in 2025, and is also a 10% owner of Revolution Medicines Inc. (RVMD) with over 5.9 million shares.[[1]](https://www.gurufocus.com/insider/126495/column-group-iii,-lp)[[3]](https://fintel.io/i/column-group-iii-gp-lp)[[4]](https://whalewisdom.com/filer/column-group-iii-gp-lp) TCG, its affiliate manager, is led by Founder and Managing Partner Peter Svennilson (35+ years in VC, founded companies sold to J&J and Roche), Managing Partner Tim Kutzkey, Ph.D. (involved in Surrozen's founding), and other partners like Haijun Chen, Ph.D., with a team of scientific and operational experts supporting investments in areas like targeted protein stabilization and therapeutics.[[5]](https://www.thecolumngroup.com/tcg-team/)

View full insider profile →

Trade Price

$19.74

Quantity

32,507

Total Value

$641,597.00

Shares Owned

2,261,777

Trade Date

Thursday, January 15, 2026

38 days ago

SEC Filing Date

Tuesday, January 20, 2026

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Surrozen, Inc./De

Company Overview

No company information available
View news mentioning SRZN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3279199

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime